-+ 0.00%
-+ 0.00%
-+ 0.00%

SCIENTURE PROVIDES COMMERCIAL UPDATE ON ARBLI™, THE FIRST FDA-APPROVED READY-TO-USE ORAL SUSPENSION OF LOSARTAN POTASSIUM

Reuters·02/03/2026 13:05:00

Please log in to view news